Print+CourseSmart

The single most readily readable source of information on psychopharmacology, covering disease and drug mechanisms in one highly illustrated volume.

Alexander (better known as "Sasha") and Ann Shulgin's foundational work in the genre was the first book to fully impart the how-to chemistry, and convey the effects, of many of the entheogenic drugs that are currently being studied and used to heal trauma and deal with death. An acronym for "Phenethylamines I Have Known and Loved", the book spans autobiography, organic chemistry, politics, ethnobotany, and psychopharmacology, and the cultural impact is likely to be profound for decades to come, as it has already. PiHKAL is divided into two parts, the first of which is a fictionalized autobiographical 'novel' - the main fiction is that it is fiction. This first half of the book is The Love Story, about two people named Shura and Alice who fall in love, though one of them is already in love with someone else. This love triangle is a painful ordeal they must go through, and that process unfolds before the reader with grace and great insight into human nature. Shura is a brilliant chemist who has dedicated his career to making psychoactive drugs, in the story they go through many experiences with the psychedelic compounds that Shura has discovered and has made in his lab, all of which have been bioassayed himself. The reader will find themselves going on this journey with them, experiencing what they experienced, both in their hearts and in the psychedelic journeys they have. The second half of PiHKAL is called The Chemical Story, and it contains detailed instructions for, and effects of, the synthesis of 179 psychedelic phenethylamines, which were mostly discovered by Shulgin himself. For each substance there is information on its synthesis, suggested effective dosage, duration, and detailed commentary on the subjective effects that were experienced. This book appeals to adults of all ages and cultures, and to the psychedelically experienced and inexperienced alike. Show Additional Fields

Responding to the controversy surrounding drug use and drug criminalization, Thomas Szasz suggests that the "therapeutic state" has overstepped its bounds in labeling certain drugs as "dangerous" substances and incarcerating drug "addicts" in order to cure them. Szasz shows that such policies scapegoat certain drugs as well as the persons who sell, buy, or use them; and 'misleadingly pathologize the "drug problem" by defining disapproved drug use as "disease" and efforts to change the behavior as "treatment." Readers will find in Szasz's arguments a cogent and committed response to a worldwide debate.

For nearly 25 years, Kaplan & Sadock's Pocket Handbook of Psychiatric Drug Treatment has been an authoritative source of up-to-date, easy-to-find information on the full spectrum of psychiatric drug therapy. Now fully revised, the Seventh Edition of this essential guide remains the drug reference of choice for psychiatrists and other physicians, as well as psychiatric residents, medical students, clinical psychologists, psychiatric nurses, and other professionals who provide care for the mentally ill.

Covering both basic science and clinical practice, this new edition of the definitive psychopharmacology text has been thoroughly updated and expanded to keep you current with the explosive growth in this burgeoning field. The book contains 62 chapters overall with 24 new chapters and 30 new authors. In four major sections, the "Textbook" covers: Principles of Psychopharmacology-provides the necessary background in neurobiology and pharmacology Classes of Psychiatric Treatment: Animal and Human Pharmacology-presents information by classes of drugs (greatly expands on second edition by focusing whole chapters on single drugs in the antidepressant, antipsychotic and bipolar categories) Clinical Psychobiology and Psychiatric Syndromes-reviews the data on the biological underpinnings of specific disorders for a better understanding of current psychopharmacological approaches Psychopharmacological Treatment-provides specific information about drug selection and their prescription Complete with a comprehensive and easy-to-use index, this new edition succeeds the second as the definitive textbook on psychopharmacology.

This fully updated new edition, which includes 16 new drugs, is the indispensable guide for all mental health prescribers.

David Healy follows his widely praised study, The Antidepressant Era, with an even more ambitious and dramatic story: the discovery and development of antipsychotic medication. Healy argues that the discovery of chlorpromazine (more generally known as Thorazine) is as significant in the history of medicine as the discovery of penicillin, reminding readers of the worldwide prevalence of insanity within living memory. But Healy tells not of the triumph of science but of a stream of fruitful accidents, of technological discovery leading neuroscientific research, of fierce professional competition and the backlash of the antipsychiatry movement of the 1960s. A chemical treatment was developed for one purpose, and as long as some theoretical rationale could be found, doctors administered it to the insane patients in their care to see if it would help. Sometimes it did, dramatically. Why these treatments worked, Healy argues provocatively, was, and often still is, a mystery. Nonetheless, such discoveries made and unmade academic reputations and inspired intense politicking for the Nobel Prize. Once pharmaceutical companies recognized the commercial potential of antipsychotic medications, financial as well as clinical pressures drove the development of ever more aggressively marketed medications. With verve and immense learning, Healy tells a story with surprising implications in a book that will become the leading scholarly work on its compelling subject.

The Psychotherapy in Clinical Practice series incorporates essential therapeutic principles into clinically relevant patient management. This first volume, Psychodynamic Theory for Clinicians, explains the major psychodynamic theories and shows how they provide a framework for clinical reasoning throughout the process of psychotherapy. Several clinical cases are presented at the beginning of the book and discussed throughout the text so readers can follow these patients in the context of each theoretical approach. Each chapter begins with learning objectives, ends with review points, and includes numerous tables, graphs, and bullet points. Appendices include a glossary, case formulation guidelines, and a comparison of psychodynamic and cognitive models.

The successor to Strain and Stitzer's Methadone Treatment for Opioid Dependence (Johns Hopkins, 1999), this expanded and updated volume reflects new developments in treatment protocols. Methadone is still the most widely used medication for the treatment of opioid dependence, and the authors provide an extensive section on methadone treatment. Three chapters cover the pharmacology and clinical use of buprenorphine as well as the latest research on Naltrexone, Clonidine, and Lofexidine. The volume also includes chapters on pain and prescription opioids as well as medication-free treatment and medically supervised alternatives to opioid substitute treatments, including withdrawal. The Treatment of Opioid Dependence will be a valuable resource for methadone counselors, psychiatrists, psychologists, social workers, mental health nurses, and addiction counselors, as well as physicians interested in office-based buprenorphine treatment.